<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018908"><a href="http://purl.obolibrary.org/obo/MONDO_0018908">MONDO:0018908</a></h3>
<p><strong>Label:</strong> non-Hodgkin lymphoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018897">MONDO:0018897</a> (primary cutaneous CD30+ T-cell lymphoproliferative disease), <a href="http://purl.obolibrary.org/obo/MONDO_0017595">MONDO:0017595</a> (aggressive b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015760">MONDO:0015760</a> (T-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004948">MONDO:0004948</a> (chronic lymphocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017594">MONDO:0017594</a> (indolent b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020511">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0004967">MONDO:0004967</a> (acute lymphoblastic leukemia (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0020325">MONDO:0020325</a> (anaplastic large cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004963">MONDO:0004963</a> (T-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0015819">MONDO:0015819</a> (indolent primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015818">MONDO:0015818</a> (aggressive primary cutaneous b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015759">MONDO:0015759</a> (b-cell non-Hodgkin lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018905">MONDO:0018905</a> (diffuse large b-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015817">MONDO:0015817</a> (aggressive primary cutaneous T-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0018906">MONDO:0018906</a> (follicular lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015816">MONDO:0015816</a> (indolent primary cutaneous T-cell lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0017604">MONDO:0017604</a> (marginal zone lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0015821">MONDO:0015821</a> (mycosis fungoides and variants), <a href="http://purl.obolibrary.org/obo/MONDO_0015758">MONDO:0015758</a> (primary cutaneous T-cell lymphoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_178548">Orphanet:178548</a>, <a href="http://www.orpha.net/ORDO/Orphanet_541">Orphanet:541</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300846">Orphanet:300846</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300842">Orphanet:300842</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178566">Orphanet:178566</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613065">OMIM:613065</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151400">OMIM:151400</a>, <a href="http://purl.obolibrary.org/obo/OMIM_247640">OMIM:247640</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613067">OMIM:613067</a>, <a href="http://www.orpha.net/ORDO/Orphanet_67038">Orphanet:67038</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613024">OMIM:613024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171901">Orphanet:171901</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615545">OMIM:615545</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612558">OMIM:612558</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612557">OMIM:612557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609630">OMIM:609630</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612559">OMIM:612559</a>, <a href="http://purl.obolibrary.org/obo/OMIM_109543">OMIM:109543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_513">Orphanet:513</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99860">Orphanet:99860</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178557">Orphanet:178557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_186770">OMIM:186770</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300912">Orphanet:300912</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178551">Orphanet:178551</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178554">Orphanet:178554</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171915">Orphanet:171915</a>, <a href="http://www.orpha.net/ORDO/Orphanet_544">Orphanet:544</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_171918">Orphanet:171918</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98841">Orphanet:98841</a>, <a href="http://www.orpha.net/ORDO/Orphanet_545">Orphanet:545</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system))) 38.98%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology))) 38.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 36.57%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0005561">HP:0005561</a> (Abnormality of bone marrow cell morphology))) 36.21%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011873">HP:0011873</a> (Abnormal platelet count))) 35.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 32.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000004">HP:0000004</a> (null))) 32.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000003">HP:0000003</a> (Multicystic kidney dysplasia))) 32.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 30.26%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 29.63%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 24.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 24.01%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 23.99%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 23.60%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 22.54%</li>
</ul>
</body>
</html>
